These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34216995)

  • 1. Cannabinoids and bladder symptoms in multiple sclerosis.
    Kim-Fine S; Greenfield J; Chaput KH; Robert M; Metz LM
    Mult Scler Relat Disord; 2021 Sep; 54():103105. PubMed ID: 34216995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.
    Rice J; Hildebrand A; Spain R; Senders A; Silbermann E; Wooliscroft L; Yadav V; Bourdette D; Cameron M
    Mult Scler Relat Disord; 2021 Oct; 55():103172. PubMed ID: 34332457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cannabis in patients with multiple sclerosis from Argentina.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Tavolini D; Mainella C; Tizio S; Tkachuk V; Silva B; Caride A; Rojas JI; Alonso R
    Mult Scler Relat Disord; 2021 Jun; 51():102932. PubMed ID: 33848817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the effects of cannabis on cognition in people with multiple sclerosis.
    Landrigan J; Bessenyei K; Leitner D; Yakovenko I; Fisk JD; Prentice JL
    Mult Scler Relat Disord; 2022 Jan; 57():103338. PubMed ID: 35158449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
    Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
    Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.
    Rice J; Hugos C; Hildebrand A; Cameron M
    Mult Scler Relat Disord; 2020 Jun; 41():102009. PubMed ID: 32086163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical cannabis use in Canadians with multiple sclerosis.
    Santarossa TM; So R; Smyth DP; Gustavsen DS; Tsuyuki DRT
    Mult Scler Relat Disord; 2022 Mar; 59():103638. PubMed ID: 35382939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis.
    Guarnaccia JB; Khan A; Ayettey R; Treu JA; Comerford B; Njike VY
    Mult Scler Relat Disord; 2021 May; 50():102830. PubMed ID: 33636612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cannabinoids in multiple sclerosis -- therapeutically reasonable?].
    Trebst C; Stangel M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):463-9. PubMed ID: 16052440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
    Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
    Brady CM; DasGupta R; Dalton C; Wiseman OJ; Berkley KJ; Fowler CJ
    Mult Scler; 2004 Aug; 10(4):425-33. PubMed ID: 15327041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms.
    Haddad F; Dokmak G; Karaman R
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use for chronic non-cancer pain: results of a prospective survey.
    Ware MA; Doyle CR; Woods R; Lynch ME; Clark AJ
    Pain; 2003 Mar; 102(1-2):211-6. PubMed ID: 12620613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cannabinoids in multiple sclerosis.
    Zajicek JP; Apostu VI
    CNS Drugs; 2011 Mar; 25(3):187-201. PubMed ID: 21323391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use as described by people with multiple sclerosis.
    Page SA; Verhoef MJ; Stebbins RA; Metz LM; Levy JC
    Can J Neurol Sci; 2003 Aug; 30(3):201-5. PubMed ID: 12945941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.